Can I use electronic signatures for consent and registration?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided you demonstrate intent, consent, attribution, and retention. For research consent involving PHI, ensure HIPAA safeguards and any institutional policies are met.

Is a Business Associate Agreement needed?

If the eSignature vendor will access or store protected health information, a HIPAA Business Associate Agreement (BAA) is required to document responsibilities and safeguards between the institution and vendor.

What authentication level should I require?

Choose authentication appropriate to risk: email or SMS for routine administrative signers, stronger methods (KBA or multi-factor) for sensitive PHI or high-assurance attestations.

How do I correct a submitted registration?

Follow your institution’s amendment or correction process. Typically submit an updated registration or amendment with a clear change log and new signatures as required by IRB and institutional policy.

Do I need IRB approval before registering?

Yes. IRB approval is generally required before enrollment or any substantive study activity, and registrations should reference the IRB protocol number and approval dates.

How long must I keep registration records?

Retain records per institutional and regulatory rules: HIPAA requires six years (45 CFR §164.530(j)); many institutions retain research records seven years or longer after closeout.

Electronic Signature
Templates
Healthcare
Healthcare Research Study Registration

Healthcare Research Study Registration

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE RESEARCH STUDY REGISTRATION

Study Identification

Study Title:

Principal Investigator: Study ID:

Study Contact Phone:

Participant Information

Participant Full Legal Name

Date of Birth: Gender: Male Female Other Prefer not to say

Address Phone Email

Emergency Contact

Name Relationship Phone

Insurance Information

Primary Insurance Provider

Policy Number: Group Number:

Subscriber Name

Medical History

Current Medications Allergies (include drug, food, and environmental) Prior Surgeries / Hospitalizations Chronic Conditions / Diagnoses

Pregnancy Status: Pregnant Not pregnant Implanted Medical Devices: Yes No

Prior Research & Eligibility

Have you participated in any clinical research study in the past 12 months? Yes No

If yes, provide study details

Permissions, Uses, and Data Handling

I authorize the study team to access and use my relevant medical records for purposes directly related to this research, including verification of medical history, laboratory data, and treatment records. I understand that records used for this research may include sensitive information. I understand that my information will be kept confidential to the fullest extent permitted by applicable law and institutional policy.

I consent to the collection and storage of biological samples as specified by the study protocol. I understand that samples may be retained for future research if I indicate consent below.

Future use of samples for research not directly related to this study: Yes No

If yes, limitations or conditions on future use

Risks, Benefits, and Compensation

Risks: Participation may involve risks and discomforts, which may be physical, psychological, social, or legal in nature. Potential risks are described in the study information sheet provided to me. I understand that unforeseen risks may occur.

Benefits: Potential benefits to me or to others are described in the study information sheet. Benefits cannot be guaranteed.

Compensation: Any compensation or reimbursement for participation is described in the study information sheet. I understand compensation may be pro-rated for early withdrawal.

Rights and Withdrawal

Voluntary Participation and Withdrawal: My participation is voluntary. I may withdraw from the study at any time without penalty and without loss of benefits to which I am otherwise entitled. If I withdraw, I authorize the study team to retain and use data and samples collected prior to withdrawal unless I specify otherwise below.

At withdrawal, please (choose one): Retain and use data/samples collected to date Destroy identifiable data/samples where feasible

Contact and Complaints

For questions about the study, contact the Principal Investigator or study team at:

For rights as a research participant or to report concerns, contact the appropriate institutional review entity at:

Privacy and HIPAA Authorization

I authorize the release of my protected health information to the study team for use in this research as described in the study information sheet. I understand that information disclosed pursuant to this authorization may include sensitive health information and that such disclosures may be re-disclosed by recipients and no longer protected by the privacy rule.

This authorization is voluntary. Refusing to sign will not affect my access to treatment or my ability to receive benefits. I may revoke this authorization in writing at any time, except to the extent that action has already been taken in reliance on it.

Authorization Expiration Date:

I acknowledge that I have received information about the study, have had the opportunity to ask questions, and understand the nature, purpose, risks, and benefits of participation.
I understand and consent to participate in this research study.

Communications Preferences

May the study team contact you for appointment reminders or study communications? Phone Email Text message Postal mail

Audio/Video Recording for research purposes: I consent to audio/video recording I do not consent

Signature

Relationship to Participant (if signing as guardian or legally authorized representative)

Participant Printed Name:

By:

Date:

Overview of the Healthcare Research Study Registration

A Healthcare Research Study Registration documents a study’s administrative details, principal investigators, sponsor information, study sites, and key protocol identifiers so institutions, review boards, and funders can track and verify research activity. Registrations commonly capture protocol title, study type, recruitment status, clinical trial identifiers, IRB approval dates, and contact information. In some cases the form also records data sharing or privacy safeguards required by institutional policies and federal rules. This record supports oversight, reproducibility, subject protection, and compliance with institutional and regulatory reporting obligations.

Why registering a study matters

Registration creates a formal record that facilitates IRB oversight, participant protections, sponsor monitoring, transparency for funders and journals, and alignment with federal and institutional reporting expectations.

Who typically completes the registration

Typical users include research administrators, principal investigators, study coordinators, and institutional compliance officers responsible for regulatory filings.

Principal investigators and lead researchers responsible for study design, protocol submission, and attestations to compliance.
Research coordinators who collect administrative data, upload attachments, and manage communications with IRBs and sponsors.
Clinical research administrators and compliance staff who verify documents, track approvals, and maintain institutional records.

Primary signers and their roles

Principal Investigator

The Principal Investigator (PI) signs to confirm protocol accuracy, subject protections, and adherence to approved procedures. The PI’s signature attests to scientific oversight and is typically required before enrollment begins; institutions may require the PI to certify training and conflict-of-interest disclosures.

Authorized Institutional Official

An authorized official (research administrator or institutional signing officer) countersigns or approves the registration to confirm institutional sponsorship, resource commitments, and compliance with institutional policies and applicable federal regulations.

Essential components of a complete registration

A professional registration form consolidates identifying details, oversight approvals, protocol metadata, site contacts, and data protections to support review and recordkeeping.

Study identifiers

Protocol title, short title, clinical trial registry number (if applicable), and internal study ID to ensure unique identification across systems and reports.

Sponsor and funder

Name of sponsor or funding source, contract or award number, and administrative contact for billing, reporting, and sponsor correspondence.

Principal investigator

Full legal name, institutional affiliation, professional title, contact phone, and institutional email used for official communications and credential checks.

IRB and approvals

Institutional Review Board name, IRB protocol number, approval date, expiration date, and any conditions or continuing review requirements.

Study sites and contacts

List of participating sites, site investigators, enrollment capacity, and local regulatory contacts for monitoring and safety reporting.

Data and privacy safeguards

Summary of data storage location, de-identification methods, HIPAA/consent language, data sharing plans, and any data use agreements.

Required information fields at a glance

Protocol title: Exact study title

PI name: Full legal name

IRB number: IRB protocol ID

Approval date: MM/DD/YYYY

Sponsor: Organization name

Data plan: Brief privacy summary

Step-by-step: completing the registration form

Follow these sequential steps to collect information, confirm approvals, and submit the registration to institutional systems or external registries.

01

Prepare documents: Collect IRB approval, protocol, consent forms, and sponsor details
02

Populate fields: Enter study identifiers, PI data, site list, and data protections
03

Verify approvals: Confirm IRB dates, signatures, and any conditions before submission
04

Submit and record: Send to registry or institutional office and archive signed copy

Typical submission flow for eRegistration

A standard electronic workflow moves documents from preparer to approver, captures signatures, and creates an audit trail for compliance and audits.

Upload: Attach protocol, consent forms, and approvals
Assign fields: Place signature, date, and initials fields for each signer
Route: Send to PI, institutional official, and sponsor reviewers
Complete: Collect signatures, generate certificate of completion

Configuring an electronic workflow for registrations

Set up a workflow that enforces signer order, field requirements, authentication methods, and archival location before sending.

Required Fields	Protocol ID, PI name, IRB number
Signer Order	PI first, then institutional official
Authentication	Email link or SMS code for signer identity
Attachments	Protocol and IRB approval PDF required
Archive Location	Institutional records system or secure cloud

Technical considerations for eSubmission

Confirm the eSignature platform supports required authentication, audit trails, and HIPAA protections before eSubmission.

Authentication options: Email link, SMS, or KBA
Document formats: PDF and Word (DOCX) accepted
Integrations: EMR/records integration supported

Timing and reporting deadlines to watch

Timelines vary by institution and funder; meet IRB and sponsor reporting windows and keep registration records current to avoid compliance gaps.

IRB renewal:

Typically annual; follow your IRB's expiration date

Sponsor reporting:

Report adverse events per sponsor schedule

Clinical trial registry:

Register before first participant enrollment when applicable

Data access requests:

Respond per institutional policy and applicable law

Final study report:

Submit to sponsor and archive per contract terms

Key milestones from protocol to archive

Sequence the registration process around critical milestones to ensure approvals and documentation precede participant activities.

01

Protocol Finalization

Draft and finalize protocol before IRB submission

02

IRB Approval

Obtain written IRB approval before recruitment

03

Registration Submission

Complete administrative registration after approvals

04

Study Closeout

Record final status and archive signed records

Common mistakes to avoid when preparing a registration

Entering an inconsistent protocol title that differs from the IRB submission, creating duplicate records and review delays.
Using informal PI names or initials instead of the PI’s full legal name, which can fail credential checks or delay approvals.
Omitting required attachments such as the IRB approval letter or consent form, resulting in administrative rejection of the registration.
Failing to declare data sharing or PHI in the registration, which can trigger corrective action during audits or sponsor reviews.

Consequences of incomplete or incorrect registration

Administrative delay: Enrollment paused

Funding risk: Payments withheld

Regulatory action: Corrective plan required

Audit findings: Negative report outcome

Reputational harm: Trust erosion

Data integrity issues: Research credibility affected

eSignature vendor comparison for study registration workflows

The table compares starting prices and selected capability indicators for common eSignature providers used in research administration.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Real-world registration examples

These concise examples show how institutions record approvals and manage administrative registration for different study types.

University Clinical Trial

A university completed a registration after IRB approval and sponsor sign-off to enable site activation.

Registry ID linked to protocol for public disclosure.
The record supported sponsor monitoring visits and streamlined multi-site reporting, reducing administrative cycles during study start-up.

Single-Site Observational Study

A clinic registered an observational cohort after confirming HIPAA waivers and consent templates.

Local PI attested to data protections and storage location.
Institutional staff archived the signed registration and attachments to meet institutional retention and audit requirements.

Practical tips for accurate and efficient registration

Adopt consistent naming, use templates, and confirm approvals before submission to reduce corrections and processing time.

Standardize titles and IDs

Use the official protocol title and a consistent internal study ID across IRB, sponsor, and registration systems to prevent duplication.

Collect approvals first

Obtain final IRB approval and any sponsor authorizations before completing the registration to avoid rejection for missing documents.

Use checklists

Maintain a submission checklist that includes attachments, signatures, and required metadata to reduce back-and-forth with administrators.

Archive signed copies

Store signed PDFs and audit trails in a secure, access-controlled repository that supports search and export for audits.

Frequently asked questions about registrations

Answers to common operational and compliance questions about completing, signing, and storing Healthcare Research Study Registrations.

Need help? Contact support

Can I use electronic signatures for consent and registration?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided you demonstrate intent, consent, attribution, and retention. For research consent involving PHI, ensure HIPAA safeguards and any institutional policies are met.
Is a Business Associate Agreement needed?
If the eSignature vendor will access or store protected health information, a HIPAA Business Associate Agreement (BAA) is required to document responsibilities and safeguards between the institution and vendor.
What authentication level should I require?
Choose authentication appropriate to risk: email or SMS for routine administrative signers, stronger methods (KBA or multi-factor) for sensitive PHI or high-assurance attestations.
How do I correct a submitted registration?
Follow your institution’s amendment or correction process. Typically submit an updated registration or amendment with a clear change log and new signatures as required by IRB and institutional policy.
Do I need IRB approval before registering?
Yes. IRB approval is generally required before enrollment or any substantive study activity, and registrations should reference the IRB protocol number and approval dates.
How long must I keep registration records?
Retain records per institutional and regulatory rules: HIPAA requires six years (45 CFR §164.530(j)); many institutions retain research records seven years or longer after closeout.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now